RIA
VRTX icon

RPG Investment Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

RPG Investment Advisory’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-9,785
Closed -$1.59M – 338
2018
Q1 		$1.59M Sell
9,785
-1,305
-12% -$213K 0.36% 72
2017
Q4 		$1.66M Sell
11,090
-140
-1% -$20.7K 0.4% 69
2017
Q3 		$1.71M Sell
11,230
-170
-1% -$25.6K 0.44% 69
2017
Q2 		$1.47M Buy
11,400
+450
+4% +$54.2K 0.4% 69
2017
Q1 		$1.2M Sell
10,950
-50
-0.5% -$4.4K 0.35% 70
2016
Q4 		$810K Sell
11,000
-300
-3% -$24.4K 0.27% 72
2016
Q3 		$985K Sell
11,300
-400
-3% -$37.8K 0.31% 76
2016
Q2 		$1.01M Sell
11,700
-100
-0.8% -$8.64K 0.27% 81
2016
Q1 		$937K Sell
11,800
-300
-2% -$27.1K 0.36% 68
2015
Q4 		$1.52M Buy
+12,100
New +$1.46M 0.57% 61

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

RPG Investment Advisory's VRTX Position: Q2 2018 in Review

RPG Investment Advisory sold out of Vertex Pharmaceuticals (VRTX) in Q2 2018, closing a stake of 9,785 shares — an estimated $1.59M sold.

RPG Investment Advisory first reported a position in VRTX in Q4 2015 and held it in 10 quarters. The position peaked at $1.71M in Q3 2017. 690 funds tracked by Wall St. Rank hold VRTX as of Q2 2018.

  • RPG Investment Advisory reported no remaining Vertex Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • RPG Investment Advisory sold 9,785 Vertex Pharmaceuticals shares in Q2 2018, an estimated $1.59M.
  • RPG Investment Advisory first reported a position in Vertex Pharmaceuticals in Q4 2015 and held it in 10 quarters.
  • RPG Investment Advisory's Vertex Pharmaceuticals position peaked at $1.71M in Q3 2017.
  • 690 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2018.

Based on RPG Investment Advisory's 13F filing for Q2 2018, filed 6 Aug 2018.